{"id":"W2067193622","doi":"10.1023/b:drug.0000026252.86842.e2","title":"A phase 1 study of OSI-211 given as an intravenous infusion days 1, 2, and 3 every three weeks in patients with solid cancers","year":2004,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":29,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen's University; Hamilton Regional Laboratory Medicine Program; BC Cancer Agency","funders":"","keywords":"Medicine; Pharmacokinetics; Neutropenia; Toxicity; Limiting; Maximum tolerated dose; Chemotherapy; Gastroenterology; Internal medicine; Surgery; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001038673,0.001418891,0.002696197,0.0004727199,0.0005876242,0.0009485965,0.0007627273,0.001232748,0.002129016],"category_scores_gemma":[0.0007762061,0.0007578774,0.001538365,0.00051994,0.001328768,0.0007441179,0.0002607581,0.003936748,0.0006018479],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009106979,"about_ca_system_score_gemma":0.001975049,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001805979,"about_ca_topic_score_gemma":0.003983532,"domain_scores_codex":[0.9996709,0.0001314314,0.000009930112,0.00006028812,0.00002436719,0.0001032661],"domain_scores_gemma":[0.9995151,0.0001218901,0.00006190322,0.00004875383,0.00002962426,0.0002226544],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7201899,0.1096645,0.006403272,0.0008940361,0.000962492,0.00051346,0.0006624283,0.004397659,0.0594,0.0006204675,0.003973012,0.09231872],"study_design_scores_gemma":[0.3074862,0.6774377,0.006700648,0.00002578091,0.0003733399,0.0002654386,0.0001024502,0.001182098,0.003890189,0.0001818347,0.002315802,0.00003852509],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953244,0.001142765,0.0003788162,0.0003436451,0.0001442424,0.001089066,0.0003926303,0.00004731129,0.001137087],"genre_scores_gemma":[0.9907271,0.002064853,0.001377514,0.000524477,0.0001734616,0.001528955,0.0009567969,0.00003621252,0.002610562],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002696197,"threshold_uncertainty_score":0.007122278,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01213914160453355,"score_gpt":0.2486694885995397,"score_spread":0.2365303469950061,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}